Biosimilars and Pharma Innovations

Biosimilars

Biosimilars are biological products that are highly similar to and have no clinically meaningful differences from an existing approved reference biologic drug. They undergo rigorous comparative testing to demonstrate similarity in terms of safety, efficacy, and quality, offering more affordable treatment options while maintaining high standards of patient care and regulatory oversight